Potassium sparing diuretics acts on :
**Core Concept:** Potassium sparing diuretics are medications that reduce urinary potassium excretion while increasing urine volume. They primarily target the renin-angiotensin-aldosterone system (RAAS) and the epithelial sodium channel (ENaC) in the distal convoluted tubule of the nephron.
**Why the Correct Answer is Right:** Potassium sparing diuretics act on the distal convoluted tubule to inhibit the epithelial sodium channel (ENaC), which reduces sodium reabsorption and increases urine volume. This leads to a decrease in the reabsorption of potassium, thereby preventing its loss in the urine and preserving its concentration in the blood.
**Why Each Wrong Option is Incorrect:**
A. This option is incorrect because it does not mention the primary mechanism of action for potassium sparing diuretics. Instead, option A focuses on the effect of aldosterone on sodium reabsorption and potassium excretion, which is unrelated to the question.
B. This option is also incorrect as it highlights the role of aldosterone in regulating sodium and potassium levels, but does not address the specific action of potassium sparing diuretics.
C. While option C mentions the role of aldosterone in the regulation of sodium and potassium levels, it does not address the specific mechanism of potassium sparing diuretics.
D. This option focuses on the role of aldosterone in regulating sodium and potassium levels but does not explain the primary mode of action for potassium sparing diuretics, which is inhibiting the epithelial sodium channel (ENaC) in the distal convoluted tubule.
**Potassium sparing diuretics:**
Potassium sparing diuretics, also known as thiazide-like diuretics, function by inhibiting the epithelial sodium channel (ENaC) in the distal convoluted tubule of the nephron. This action results in a decrease in sodium reabsorption and an increase in urine volume, while preserving potassium levels in the blood.
**Clinical Pearl:** Potassium sparing diuretics are commonly prescribed in cases of hypertension and congestive heart failure to reduce sodium and water retention, and to prevent potassium loss. They work by inhibiting the epithelial sodium channel in the distal convoluted tubule of the nephron, thereby preventing excessive potassium loss and lowering blood pressure.
**Why Option D is Right:** Option D correctly highlights the primary mode of action for potassium sparing diuretics, which is inhibiting the epithelial sodium channel (ENaC) in the distal convoluted tubule. This prevents excessive sodium loss and contributes to the overall therapeutic effect of these medications in hypertension and congestive heart failure.